Literature DB >> 7861153

Tau self-association: stabilization with a chemical cross-linker and modulation by phosphorylation and oxidation state.

R P Guttmann1, A C Erickson, G V Johnson.   

Abstract

tau is a major component of paired helical filaments found in the neurofibrillary tangles of Alzheimer's diseased brain. However, the mechanism or mechanisms responsible for the association of tau to form these aggregates remains unknown. In this study, the role of intermolecular disulfide bonds in the formation of higher order oligomers of bovine tau and the human recombinant tau isoform T3 was examined using the chemical cross-linking agent disuccinimidylsuberate (DSS). In addition, the role of phosphorylation and oxidation state on the in vitro self-association of tau was studied using this experimental model. Stabilization of tau-tau interactions with DSS indicated that intermolecular disulfide bonds probably play a predominant role in dimer formation, but the formation of higher order oligomers of tau cannot be attributed to these bonds alone. tau-tau interactions were significantly decreased either by blocking Cys residues or by exposing the tau to a reducing (nitrogen and dithiothreitol), instead of an oxidizing, environment. tau self-association was also significantly decreased by prior phosphorylation with calcium/calmodulin-dependent protein kinase II. Phosphorylation by cyclic AMP-dependent protein kinase or dephosphorylation by alkaline phosphatase did not alter tau self-assembly. These data suggest a role for several factors that may modulate tau self-association in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7861153     DOI: 10.1046/j.1471-4159.1995.64031209.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

Review 1.  Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration.

Authors:  M L Billingsley; R L Kincaid
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

2.  Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease.

Authors:  Kristina R Patterson; Christine Remmers; Yifan Fu; Sarah Brooker; Nicholas M Kanaan; Laurel Vana; Sarah Ward; Juan F Reyes; Keith Philibert; Marc J Glucksman; Lester I Binder
Journal:  J Biol Chem       Date:  2011-05-06       Impact factor: 5.157

3.  The formation of small aggregates contributes to the neurotoxic effects of tau45-230.

Authors:  Sana Afreen; Adriana Ferreira
Journal:  Neurochem Int       Date:  2021-11-29       Impact factor: 3.921

4.  The Neurotoxic TAU45-230 Fragment Accumulates in Upper and Lower Motor Neurons in Amyotrophic Lateral Sclerosis Subjects.

Authors:  Claudia R Vintilescu; Sana Afreen; Ashlee E Rubino; Adriana Ferreira
Journal:  Mol Med       Date:  2016-08-03       Impact factor: 6.354

5.  E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures.

Authors:  T J Montine; V Amarnath; M E Martin; W J Strittmatter; D G Graham
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

Review 6.  Tau therapeutics for Alzheimer's disease: the promise and the challenges.

Authors:  Michael Gold
Journal:  J Mol Neurosci       Date:  2002-12       Impact factor: 3.444

7.  Tau protein is phosphorylated by cyclic AMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356.

Authors:  J M Litersky; G V Johnson; R Jakes; M Goedert; M Lee; P Seubert
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

8.  Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments.

Authors:  O Schweers; E M Mandelkow; J Biernat; E Mandelkow
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.